Skip to main content

Respiratory Distress Syndrome clinical trials at UC Irvine

2 in progress, 1 open to eligible people

Showing trials for
  • Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

    open to eligible people ages 18 years and up

    BTI-203 is a randomized, double-blind, placebo-controlled, multicenter, Phase 2 proof-of-concept (POC) study to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤150) due to pneumonia or other infections. Potential subjects hospitalized with pneumonia or other infections are to be screened within 24 hours of diagnosis of ARDS.

    Irvine, California and other locations

  • Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants

    Sorry, in progress, not accepting new patients

    This study is being conducted to determine whether prophylactic administration of surfactant by the Less Invasive Surfactant Administration (LISA) method reduces the need for mechanical ventilation in the first 72 hours of life when compared to early Continuous Positive Airway Pressure (CPAP) alone.

    Irvine, California and other locations

Our lead scientists for Respiratory Distress Syndrome research studies include .

Last updated: